In 2023, Cindy and Lou Campbell were interviewed for a second time—ten years later—by Tom Llamas of NBC News. During the conversation, the Campbells reflected on the growth of the Ty Louis Campbell Foundation, the progress made in advancing its mission in memory of their son Ty, and the ongoing challenges facing the childhood cancer [...]
Expanding our footprint in advancing precision medicine for children with malignant brain tumors, we are funding Dr. Samuel H. Cheshier, MD, PhD, to lead an innovative precision medicine program at Intermountain Primary Children’s Hospital that tailors treatment to each child’s unique brain tumor. Over the past four years, this approach has already been applied successfully to [...]
Dr. Eric Raabe of Johns Hopkins University is leading innovative research to tackle ATRT by addressing one of its root causes: faulty gene control that keeps tumor cells locked in an immature, aggressive state. This preclinical project tests a promising new drug called corin, which targets a key epigenetic protein complex that ATRT cells rely [...]
Embryonal tumor with multilayered rosettes (ETMR) is one of the rarest and most aggressive brain tumors affecting very young children, and relapse is heartbreakingly common. Dr. Johannes Gojo of the Medical University of Vienna is leading a forward-thinking research project to understand why ETMR tumors return and how resistant cancer cells manage to survive treatment. [...]
